Login
Super Investors / COWEN AND COMPANY, LLC
CA

COWEN AND COMPANY, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
Positions
1
Quarter ended
December 31, 2024
Filed
February 14, 2025

Reported portfolio value by quarter (22 quarters reported)

$3.64B
Q3 19 Q4 20 Q1 22 Q2 23 Q3 24 Q4 24

$394M in Q3 2019 → — now. Hover for any quarter.

Holdings

As reported for the quarter ended December 31, 2024. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
N N/a NaN% New 0

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Nvidia Corporation Exited −5,559,626 −$675M
Coinbase Global Inc Exited −1,275,333 −$227M
Meta Platforms Inc Exited −309,820 −$177M
Amazon Com Inc Exited −769,822 −$143M
Microsoft Corp Exited −327,257 −$141M
Ptc Therapeutics Inc Exited −3,590,655 −$133M
Apple Inc Exited −523,959 −$122M
Eli Lilly & Co Exited −130,399 −$116M
Tesla Inc Exited −308,553 −$80.7M
Tarsus Pharmaceuticals Inc Exited −2,197,385 −$72.3M

Showing the 10 largest of 617 changes.

Q3 2024

quarter ended September 30, 2024 · filed November 12, 2024

Company Action Shares changed Value of change % of portfolio
Meta Platforms Inc Trimmed −463,835 −$266M 6.0%
Avidity Biosciences Inc Exited −5,129,103 −$210M
Apple Inc Trimmed −820,528 −$191M 4.1%
Microsoft Corp Added +280,640 +$121M 4.7%
Eli Lilly & Co New +130,399 +$116M 3.9%
Advanced Micro Devices Inc Trimmed −650,124 −$107M 1.8%
Alphabet Inc Exited −500,000 −$91.7M
Nike Inc Trimmed −1,007,700 −$89.1M
Alphabet Inc New +419,077 +$69.5M 2.3%
Coinbase Global Inc Trimmed −213,642 −$38.1M 7.7%

Showing the 10 largest of 731 changes.

Q2 2024

quarter ended June 30, 2024 · filed August 07, 2024

Company Action Shares changed Value of change % of portfolio
Nvidia Corporation Added +5,058,156 +$625M 19.7%
Meta Platforms Inc Added +486,023 +$245M 10.7%
Apple Inc Added +1,114,519 +$235M 7.8%
Advanced Micro Devices Inc Added +933,783 +$151M 4.3%
Amazon Com Inc Added +667,289 +$129M 3.6%
Alphabet Inc New +500,000 +$91.7M 2.5%
Nike Inc New +1,007,841 +$76M 2.1%
Tesla Inc New +239,384 +$47.4M 1.3%
PJ Papa Johns Intl Inc New +696,800 +$32.7M 0.9%
AA Ares Acquisition Corp Ii Added +3,000,331 +$32M 1.0%

Showing the 10 largest of 730 changes.

Q1 2024

quarter ended March 31, 2024 · filed May 03, 2024

Company Action Shares changed Value of change % of portfolio
Coinbase Global Inc Added +1,170,433 +$310M 15.8%
Nvidia Corporation Added +201,023 +$182M 26.2%
Meta Platforms Inc Added +248,167 +$121M 5.4%
Protagonist Therapeutics Inc New +1,557,636 +$45.1M 1.7%
Apple Inc Added +196,456 +$33.7M 1.5%
SS Select Sector SPDR Tr Exited −393,602 −$33M
SM Sumitomo Mitsui Finl Group I New +2,800,730 +$33M 1.3%
SE Screaming Eagle Acquisitn Co Trimmed −2,845,419 −$30.4M
IH Immunocore Hldgs PLC Trimmed −415,395 −$27M 0.3%
Imperial Oil Ltd Exited −433,016 −$24.7M

Showing the 10 largest of 702 changes.

Q4 2023

quarter ended December 31, 2023 · filed February 12, 2024

Company Action Shares changed Value of change % of portfolio
Ptc Therapeutics Inc Added +2,926,115 +$80.6M 6.7%
AT Advisorshares Tr Exited −6,139,280 −$48.7M
Ares Acquisition Corporation Exited −3,385,401 −$36.4M
Coinbase Global Inc Added +206,395 +$35.9M 4.2%
Sage Therapeutics Inc New +1,339,971 +$29M 1.9%
Protagonist Therapeutics Inc Exited −1,657,551 −$27.6M
Imperial Oil Ltd New +433,016 +$24.7M 1.6%
A& Agriculture & Nat Sol Acq Co New +2,135,000 +$21.7M 1.4%
AE Ark ETF Tr New +384,920 +$20.2M 1.3%
SE Screaming Eagle Acquisitn Co Added +1,652,818 +$17.5M 2.0%

Showing the 10 largest of 776 changes.

Q3 2023

quarter ended September 30, 2023 · filed November 09, 2023

Company Action Shares changed Value of change % of portfolio
Nvidia Corporation Added +377,971 +$164M 17.4%
SS Select Sector SPDR Tr New +555,802 +$50.2M 3.5%
MM Magellan Midstream Prtnrs LP Exited −725,000 −$45.2M
Churchill Capital Corp Vii New +2,800,465 +$29.3M 2.0%
AT Advisorshares Tr Added +3,573,000 +$28.4M 3.4%
SM Sumitomo Mitsui Finl Group I Exited −2,800,730 −$24.1M
Sirius Xm Holdings Inc Added +4,376,000 +$19.8M 2.0%
NE Nabors Energy Transition Cor New +1,677,458 +$17.1M 1.2%
MI Mercer Intl Inc Added +1,900,000 +$16.3M 2.0%
EO Elliott Opportunity Ii Corp Exited −1,463,962 −$15.2M

Showing the 10 largest of 719 changes.

Q2 2023

quarter ended June 30, 2023 · filed August 07, 2023

Company Action Shares changed Value of change % of portfolio
Sylvamo Corp Exited −2,150,000 −$99.5M
Nvidia Corporation New +192,750 +$81.5M 6.8%
Protagonist Therapeutics Inc New +1,657,551 +$45.8M 3.8%
MM Magellan Midstream Prtnrs LP New +725,000 +$45.2M 3.7%
Tarsus Pharmaceuticals Inc New +1,999,383 +$36.1M 3.0%
Ptc Therapeutics Inc New +799,511 +$32.5M 2.7%
KV Khosla Ventures Acqut Co Iii Exited −2,410,664 −$24.5M
TT Tio Tech A Exited −2,176,071 −$22.2M
Immunovant Inc Exited −1,250,000 −$19.4M
Avadel Pharmaceuticals PLC Trimmed −1,068,702 −$17.6M 3.6%

Showing the 10 largest of 701 changes.

Q1 2023

quarter ended March 31, 2023 · filed May 09, 2023

Company Action Shares changed Value of change % of portfolio
DM Dcp Midstream LP Exited −1,516,562 −$58.8M
RT Revance Therapeutics Inc Exited −36,600,000 −$34.3M
Dish Network Corporation Exited −45,367,000 −$28.5M
SC Sciplay Corporation Trimmed −1,536,246 −$26.1M
Scpharmaceuticals Inc New +2,807,562 +$25.5M 3.0%
KV Khosla Ventures Acqut Co Iii New +2,410,664 +$24.5M 2.9%
TT Tio Tech A New +2,176,071 +$22.2M 2.6%
Stoke Therapeutics Inc Added +2,531,065 +$21.1M 3.2%
Ares Acquisition Corporation New +1,304,228 +$13.5M 1.6%
CC Churchill Capital Corp V Added +1,248,295 +$12.6M 1.7%

Showing the 10 largest of 785 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support